Search research articles
Contact Us
Filters
Showing results (71-80 of 131) with videos related to
Page
of 14
Sort By:
Clinical Pharmacology in Drug Development
|
May 11, 2016
Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease
José-Francisco Rocha, Joaquim J Ferreira, Amílcar Falcão, et al.
The Journal of Cell Biology
|
September 20, 2018
Occluding junctions as novel regulators of tissue mechanics during wound repair
Lara Carvalho, Pedro Patricio, Susana Ponte, et al.
Current Medical Research and Opinion
|
April 10, 2010
Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects
Teresa Nunes, Eric Sicard, Luis Almeida, et al.
Lung India : Official Organ of Indian Chest Society
|
July 14, 2021
Clinical impact of obesity on respiratory diseases: A real-life study
Arturo Cortes-Telles, Diana Lizbeth Ortiz-Farias, Yuri NoemI Pou-Aguilar, et al.
CNS Neuroscience & Therapeutics
|
July 27, 2010
A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in Parkinson's disease
Joaquim J Ferreira, Olivier Rascol, Werner Poewe, et al.
British Journal of Clinical Pharmacology
|
October 31, 2013
Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β-hydroxylase inhibitor
Ana I Loureiro, Jose F Rocha, Carlos Fernandes-Lopes, et al.
Drugs in R&D
|
July 5, 2005
Effect of food on the pharmacokinetic profile of eslicarbazepine acetate (BIA 2-093)
Joana Maia, Manuel Vaz-da-Silva, Luis Almeida, et al.
Drugs in R&D
|
September 1, 2005
Eslicarbazepine acetate (BIA 2-093) : relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200mg and 800mg tablet formulations
Carlos Fontes-Ribeiro, Teresa Nunes, Amilcar Falcão, et al.
Epilepsia
|
July 29, 2010
Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy
Peter Halász, Joyce A Cramer, Danilo Hodoba, et al.
Epilepsy & Behavior : E&B
|
August 17, 2010
Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers
Denise Milovan, Luis Almeida, Myroslava K Romach, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 131) with videos related to
Sort By:
Page
of 14
Clinical Pharmacology in Drug Development
|
May 11, 2016
Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease
José-Francisco Rocha, Joaquim J Ferreira, Amílcar Falcão, et al.
The Journal of Cell Biology
|
September 20, 2018
Occluding junctions as novel regulators of tissue mechanics during wound repair
Lara Carvalho, Pedro Patricio, Susana Ponte, et al.
Current Medical Research and Opinion
|
April 10, 2010
Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects
Teresa Nunes, Eric Sicard, Luis Almeida, et al.
Lung India : Official Organ of Indian Chest Society
|
July 14, 2021
Clinical impact of obesity on respiratory diseases: A real-life study
Arturo Cortes-Telles, Diana Lizbeth Ortiz-Farias, Yuri NoemI Pou-Aguilar, et al.
CNS Neuroscience & Therapeutics
|
July 27, 2010
A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in Parkinson's disease
Joaquim J Ferreira, Olivier Rascol, Werner Poewe, et al.
British Journal of Clinical Pharmacology
|
October 31, 2013
Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine β-hydroxylase inhibitor
Ana I Loureiro, Jose F Rocha, Carlos Fernandes-Lopes, et al.
Drugs in R&D
|
July 5, 2005
Effect of food on the pharmacokinetic profile of eslicarbazepine acetate (BIA 2-093)
Joana Maia, Manuel Vaz-da-Silva, Luis Almeida, et al.
Drugs in R&D
|
September 1, 2005
Eslicarbazepine acetate (BIA 2-093) : relative bioavailability and bioequivalence of 50 mg/mL oral suspension and 200mg and 800mg tablet formulations
Carlos Fontes-Ribeiro, Teresa Nunes, Amilcar Falcão, et al.
Epilepsia
|
July 29, 2010
Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy
Peter Halász, Joyce A Cramer, Danilo Hodoba, et al.
Epilepsy & Behavior : E&B
|
August 17, 2010
Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers
Denise Milovan, Luis Almeida, Myroslava K Romach, et al.
Page
of 14